Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 5—May 2025
Research
Powassan and Eastern Equine Encephalitis Virus Seroprevalence in Endemic Areas, United States, 2019–2020
Table 1
Demographics of blood donors tested for POWV and EEEV and disease cases and population census of selected counties of residence in study of seroprevalence in endemic areas, United States, 2019–2020*
Demographics | No. disease cases reported, 2010–2019 |
2020 US Census population, age >15 y | No. (%) specimens tested |
||
---|---|---|---|---|---|
POWV | EEEV | POWV | EEEV | ||
Sex | |||||
F | 835 (47.2) | 276 (48.7) | |||
M |
935 (52.8) |
291 (51.3) |
|||
Age group, y | |||||
16–29 | 225 (12.7) | 65 (11.5) | |||
30–49 | 436 (24.6) | 147 (25.9) | |||
50–64 | 751 (42.4) | 243 (42.9) | |||
>65 |
358 (20.2) |
112 (19.8) |
|||
State/county of residence | |||||
Connecticut | |||||
Fairfield | 3 | 771,950 | 420 | ||
Litchfield | 2 | 155,110 | 164 | ||
New London | 3 | 224,538 | 17 | ||
Massachusetts | |||||
Barnstable | 5 | 187,694 | 21 | ||
Bristol | 4 | 467,915 | 36 | ||
Essex | 9 | 3 | 650,007 | 184 | 49 |
Middlesex | 10 | 3 | 1,343,808 | 337 | 100 |
Norfolk | 2 | 583,823 | 206 | ||
Plymouth | 4 | 428,646 | 32 | ||
Worcester | 2 | 4 | 684,405 | 160 | 52 |
Michigan | |||||
Berrien | 2 | 126,184 | 81 | ||
Cass | 2 | 42,929 | 24 | ||
Kalamazoo | 5 | 216,792 | 137 | ||
Van Buren | 2 | 60,928 | 39 | ||
Minnesota | |||||
Anoka | 5 | 284,136 | 141 | ||
Cass | 2 | 24,286 | 3 | ||
Itasca | 7 | 37,544 | 8 | ||
Morrison | 3 | 26,551 | 8 | ||
Wisconsin | |||||
Jackson | 2 | 16,881 | 16 | ||
Shawano | 2 | 33,692 | 3 | ||
Trempealeau | 2 | 23,357 | 19 | ||
Wood | 2 | 59,811 | 80 | ||
Total | 1,770 | 567 |
*Blank cells indicate not applicable. EEEV, Eastern equine encephalitis virus; POWV, Powassan virus.
Page created: March 18, 2025
Page updated: April 25, 2025
Page reviewed: April 25, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.